Beck Bode’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-5,018
Closed -$273K – 104
2026
Q2
$273K Buy
5,018
+31
+0.6% +$1.51K 0.04% 88
2026
Q1
$214K Sell
4,987
-402
-7% -$17.3K 0.04% 88
2025
Q4
$236K Sell
5,389
-215
-4% -$8.89K 0.04% 89
2025
Q3
$231K Buy
+5,604
New +$225K 0.04% 89

Other funds holding EXEL

Beck Bode's EXEL Position: Q3 2026 in Review

Beck Bode sold out of Exelixis (EXEL) in Q3 2026, closing a stake of 5,018 shares — an estimated $273K sold.

Beck Bode first reported a position in EXEL in Q3 2025 and held it in 4 quarters. The position peaked at $273K in Q2 2026. 637 funds tracked by Wall St. Rank hold EXEL as of Q3 2026.

  • Beck Bode reported no remaining Exelixis position as of Q3 2026 after selling out during the quarter.
  • Beck Bode sold 5,018 Exelixis shares in Q3 2026, an estimated $273K.
  • Beck Bode first reported a position in Exelixis in Q3 2025 and held it in 4 quarters.
  • Beck Bode's Exelixis position peaked at $273K in Q2 2026.
  • 637 funds tracked by Wall St. Rank held Exelixis as of Q3 2026.

Based on Beck Bode's 13F filing for Q3 2026, filed 12 Nov 2026.